Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV
Clinical trial NCT00539864 · COMPLETED
Trial details
- NCT number
- NCT00539864
- Sponsor
- Protein Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-04-01
- Enrollment
- 602
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.